ClinicalTrials.gov
public full text
Public Domain
Effects of Mesna on Homocysteine in Kidney Failure
The purpose of this research study is to examine the effect of a drug called mesna on the removal of homocysteine from blood during dialysis. Homocysteine is an amino acid (protein building block) found in the blood of all people, however it is considerably elevated in dialysis patients. People with increased levels of homocysteine in their blood are at increased risk of developing plaque buildup in their arteries and other related problems such as heart attack and stroke. This study will determine if mesna can improve the rate of homocysteine removal from blood during dialysis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Hemodialysis.-Induced Hypotension Therapy for End Stage Kidney Disease#1141029
- Theranova vs High-flux HD Comparison#1060630
- An Investigation of N-acetylcysteine and Fenoldopam as Renal Protection Agents for Cardiac Surgery#1372251
- Prevention of Nephrotoxin-Induced Acute Kidney Injury Using Cilastatin#1370310
- The Acetylcysteine for Contrast-Induced Nephropathy Trial#1072570
Record · ID 1282374
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive